Related Experiment Video
Updated: Jul 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov chains
Rosalba Rosato1, G Ciccone, S Bo
1Unit of Cancer Epidemiology, S. Giovanni Battista Hospital and University of Turin and CPO Piemonte, Italy. r_rosato@yahoo.com
The Aalen model better predicts mortality risk in type 2 diabetes patients with severe conditions compared to the Cox model. This finding aids in developing better diabetes care analytics and resource management.
Area of Science:
- Epidemiology
- Biostatistics
- Diabetology
Background:
- Type 2 diabetes is strongly linked to increased cardiovascular mortality.
- Accurate prediction of mortality causes is crucial for effective patient management.
Purpose of the Study:
- To estimate cause-specific mortality using Cox and Aalen models.
- To assess how covariate patterns influence mortality predictions.
- To compare the performance of different statistical methods.
Main Methods:
- Cox and Aalen additive regression models with Markov chain approach.
- Analysis of a cohort of 2865 type 2 diabetic patients (no insulin).
- Comparison of model accuracy for varying patient severity.
Main Results:
- Models showed similar cumulative incidence functions for patients with favorable profiles.
- Significant differences emerged for patients with severe profiles; Cox model: 0.26 (95% CI 0.21-0.31) vs. Aalen model: 0.14 (95% CI 0.09-0.18) for cardiovascular mortality.
- Aalen model demonstrated superior risk estimation for severe cases.
Conclusions:
- Both Cox and Aalen models effectively capture risk for average profiles.
- Aalen model is superior for identifying cause-specific mortality risk in severe type 2 diabetes cases.
- Findings support the development of advanced analytical tools for diabetes care research and resource allocation.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Comparing the Survival Analysis of Two or More Groups
Type II Diabetes II: Pathophysiology
Complications of Diabetes Mellitus
Kaplan-Meier Approach
Type II Diabetes I: Introduction
